ETEX Corp. inked a non-exclusive deal with an Indiana company to distribute a bone putty used in spinal fusion treatments.
OrthoPediatrics Corp. will sell the Cambridge, Mass.-based company’s nanocrystalline calcium phosphate into the pediatric market in the U.S. and Canada. The product is used in spinal fusion procedures to fill bone voids or skeletal defects "that are not intrinsic to the stability of the bone structure," according to a press release.
ETEX makes a trio of bone products: EquivaBone, a moldable, injectable putty made of nanocrystalline calcium phosphate and demineralized bone matrix used in posterolateral spine fusion procedures; Beta-bsm, an injectable paste; and a moldable putty called Gamma-bsm. The latter two are designed to create a scaffold to promote new bone growth, according to the press release.
Registration is open for DeviceTalks Boston! Join us on June 5-6, 2019, as we explore the trends and technology that are shaping the future of the medical device industry.